Quick Summary:
The Oral Solid Dosage Forms (OSDF) and Pharma Excipients market is positioned for substantial growth, with predicted reaches of $1.6 billion by 2030. With intricate analysis of key segments, such as Polymers forecasting to record a 6.3% CAGR, this comprehensive market research report presents an invaluable asset for senior executives in the pharmaceutical industry. Delve into a detailed diagnosis of the promising trends in the aftermath of the global health eco-system recovery.
In this highly competitive market, understanding regional disparities and growth potentials is paramount for strategic decision-making. With the U.S. Market estimated at $319.5 Million and China forecasting a growth at 4.7% CAGR, sector leaders need to stay ahead with the latest market insights and competitor analysis. The report also includes access to a digital archive, online collaborative updates and complimentary updates for one year, ensuring you're consistently abreast with the rapid changes in the industry.
Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market to Reach $1.6 Billion by 2030
The global market for Oral Solid Dosage Forms (OSDF) and Pharma Excipients estimated at US$1.1 Billion in the year 2022, is projected to reach a revised size of US$1.6 Billion by 2030, growing at a CAGR of 5.2% over the analysis period 2022-2030. Polymers, one of the segments analyzed in the report, is projected to record 6.3% CAGR and reach US$846.6 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Alcohols segment is readjusted to a revised 4.5% CAGR for the next 8-year period.
The U.S. Market is Estimated at $319.5 Million, While China is Forecast to Grow at 4.7% CAGR
The Oral Solid Dosage Forms (OSDF) and Pharma Excipients market in the U.S. is estimated at US$319.5 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$280.7 Million by the year 2030 trailing a CAGR of 4.7% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.6% and 4.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.Select Competitors (Total 46 Featured) -
- Abitec Corporation
- Akzo Nobel NV
- Archer Daniels Midland Company
- Associated British Foods PLC
- Avantor Performance Materials LLC
- BASF SE
- Cabot Corporation
- Cargill, Inc.
- Celanese Corporation
- Croda International PLC
- Dow, Inc.
- DuPont de Nemours, Inc.
- Eastman Chemical Company
- Ferro Corporation
- FMC Corporation
- FMC Corporation
- Huntsman Corporation
- Ingredion, Inc.
- Innophos Holdings, Inc.
- J.M. Huber Corporation
- Kuraray Co., Ltd.
- Medtronic PLC
- Merck KGaA
- Nitta Gelatin, Inc.
- Procter & Gamble Company, The
- Royal Dutch Shell PLC
- The Lubrizol Corporation
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and the publisher's Research Platform
- Complimentary updates for one year
What is the estimated value of the Global Market for Oral Solid Dosage Forms (OSDF) and Pharma Excipients?
What is the growth rate of the Global Market for Oral Solid Dosage Forms (OSDF) and Pharma Excipients?
What is the forecasted size of the Global Market for Oral Solid Dosage Forms (OSDF) and Pharma Excipients?
Who are the key companies in the Global Market for Oral Solid Dosage Forms (OSDF) and Pharma Excipients?
| Report Attribute | Details |
|---|---|
| No. of Pages | 196 |
| Published | September 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 1.1 Billion |
| Forecasted Market Value ( USD | $ 1.6 Billion |
| Compound Annual Growth Rate | 4.8% |
| Regions Covered | Global |
Table of Contents
Companies Mentioned
A selection of companies mentioned in this report includes:
- Abitec Corporation
- Akzo Nobel NV
- Archer Daniels Midland Company
- Associated British Foods PLC
- Avantor Performance Materials LLC
- BASF SE
- Cabot Corporation
- Cargill, Inc.
- Celanese Corporation
- Croda International PLC
- Dow, Inc.
- DuPont de Nemours, Inc.
- Eastman Chemical Company
- Ferro Corporation
- FMC Corporation
- FMC Corporation
- Huntsman Corporation
- Ingredion, Inc.
- Innophos Holdings, Inc.
- J.M. Huber Corporation
- Kuraray Co., Ltd.
- Medtronic PLC
- Merck KGaA
- Nitta Gelatin, Inc.
- Procter & Gamble Company, The
- Royal Dutch Shell PLC
- The Lubrizol Corporation
